The effect of age on hepatic gene transfer with self-inactivating lentiviral vectors in vivo

Molecular Therapy

Volumn 8, Issue 2, 2003, Pages 314-323

  Park, Frank ^a   Ohashi, Kazuo ^b   Kay, Mark A ^b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Human 1 antitrypsin; Immune system; lacZ; Matrix attachment region; Proliferation

Indexed keywords

ALPHA 1 ANTITRYPSIN; BETA LACTAMASE; COMPLEMENTARY DNA; IMMUNOGLOBULIN KAPPA CHAIN; LENTIVIRUS VECTOR;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSDUCTION; IMMUNE RESPONSE; IN VIVO STUDY; LIVER; LIVER DEVELOPMENT; MALE; MOUSE; NONHUMAN; PROMOTER REGION; PROTEIN BLOOD LEVEL; TISSUE SECTION; VIRAL GENE THERAPY; VIRUS INACTIVATION;

ANIMALIA; BACTERIA (MICROORGANISMS); LENTIVIRUS;

EID: 0041854301     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1525-0016(03)00169-2     Document Type: Article

References (35)

1. Ghosh, S. S., Takahashi, M., Thummala, N. R., Parashar, B., Chowdhury, N. R., and Chowdhury, J. R. (2000). Liver-directed gene therapy: promises, problems and prospects at the turn of the century. J. Hepatol. 32(Suppl.): 238-252.
2. Naldini, L, et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
3. Zennou, V, et al. (2001). The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat. Biotechnol. 19: 446-450.
4. Blomer, U., Naldini, L., Kafri, T., Trono, D., Verma, I. M., and Gage, F. H. (1997). Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71: 6641-6649.
5. Johnston, J. C., et al. (1999). Minimum requirements for efficient transduction of dividing and nondividing cells by feline immunodeficiency virus vectors. J. Virol. 73: 4991-5000.
6. Takahashi, M., Miyoshi, H., Verma, I. M., and Gage, F. H. (1999). Rescue from photo-receptor degeneration in the rd mouse by human immunodeficiency virus vector-mediated gene transfer. J. Virol. 73: 7812-7816.
7. Ohashi, K., Park, F., and Kay, M. A. (2002). Role of hepatocyte direct hyperplasia in lentivirus-mediated liver transduction in vivo. Hum. Gene Ther. 13: 653-664.
8. Park, F., and Kay, M. A. (2001). Modified HIV-1-based lentiviral vectors have an effect on viral transduction efficiency and transgene expression in vitro and in vivo. Mol. Ther. 4: 164-173.
9. Park, F., Ohashi, K., Chiu, W., Naldini, L., and Kay, M. A. (2000). Efficient lentiviral transduction of liver requires cell cycling in vivo. Nat. Genet. 24: 49-53.
10. Park, F., Ohashi, K., and Kay, M. A. (2000). Therapeutic levels of human factors VIII and IX using HIV-1-based lentiviral vectors in mouse liver. Blood 96: 1173-1176.
11. Tsui, L. V., et al. (2002). Production of human clotting factor IX without toxicity in mice after vascular delivery of a lentiviral vector. Nat. Biotechnol. 20: 53-57.
12. Follenzi, A., Sabatino, G., Lombardo, A., Boccaccio, C., and Naldini, L. (2002). Efficient gene delivery and targeted expression to hepatocytes in vivo by improved lentiviral vectors. Hum. Gene Ther. 13: 243-260.
13. Sutton, R. E., Reitsma, M. J., Uchida, N., and Brown, P. O. (1999). Transduction of human progenitor hematopoietic stem cells by human immunodeficiency virus type 1-based vectors is cell cycle dependent. J. Virol. 73: 3649-3660.
14. Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., and Charneau, P. (2000). HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101: 185-193.
15. Follenzi, A., Ailles, L. E., Bakovic, S., Geuna, M., and Naldini, L. (2000). Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences. Nat. Genet. 25: 217-222.
16. Pastore, L., et al. (1999). Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors. Hum. Gene Ther. 10: 1773-1781.
17. Miao, C. H., et al. (2000). Inclusion of the hepatic locus control region, an intron, and an untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Mol. Ther. 1: 522-532.
18. MacSween, R. N. M., Desmet, V. J., Roskams, T., and Scothorne, R. J. (2002). Developmental anatomy and normal structure. In Pathology of the Liver (R. N. M. MacSween, A. D. Burt, B. C. Portmann, K. G. Ishak, P. J. Scheuer, and P. P. Anthony, Eds.), pp. 1-66. Churchill Livingstone, New York.
19. VandenDriessche, T., et al. (1999). Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice. Proc. Natl. Acad. Sci. USA 96: 10379-10384.
20. VandenDriessche, T., et al. (2002). Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivo. Blood 100: 813-822.
21. Tarantal, et al. (2001). Lentiviral vector gene transfer into fetal rhesus monkeys (Macaca mulatta): lung-targeting approaches. Mol. Ther. 4: 614-621.
22. Zahler, M. H., et al. (2000). The application of a lentiviral vector for gene transfer in fetal human hepatocytes. J. Gene Med. 2: 186-193.
23. Ohashi, K., Park, F., and Kay, M. A. (2002). Efficient gene transduction to cultured hepatocytes by HIV-1 derived lentiviral vector. Transplant. Proc. 34: 1431-1433.
24. Nguyen, T. H., Oberholzer, J., Birraux, J., Maino, P., Morel, P., and Trono, D. (2002). Highly efficient lentiviral vector-mediated transduction of nondividing, fully implantable primary hepatocytes. Mol. Ther. 6: 199-209.
25. Pfeifer, A., et al. (2001). Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging. Mol. Ther. 3: 319-322.
26. Dull, T., et al. (1998). A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72: 8463-8471.
27. 1-antitrypsin in vivo. Hum. Gene Ther. 7: 637-645.
28. Miao, C. H., Thompson, A. R., Loeb, K., and Ye, X. (2001). Long-term and therapeutic level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. Mol. Ther. 3: 947-957.
29. Schiedner, G., Hertel, S., Johnston, M., Biermann, V., Dries, V., and Kochanek, S. (2002). Variables affecting in vivo performance of high-capacity adenovirus vectors. J. Virol. 76: 1600-1609.
30. Schowalter, D. B., Himeda, C. L., Winther, B. L., Wilson, C. B., and Kay, M. A. (1999). Implication of interfering antibody formation and apoptosis as two different mechanisms leading to variable duration of adenovirus-mediated transgene expression in immune-competent mice. J. Virol. 73: 4755-4766.
31. Schowalter, D. B., Meuse, L., Wilson, C. B., Linsley, P. S., and Kay, M. A. (1997). Constitutive expression of murine CTLA4 19 from a recombinant adenovirus results in prolonged transgene expression. Gene Ther. 4: 853-860.
32. 1-antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors. Gene Ther. 8: 1299-1306.
33. Zufferey, R., et al. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72: 9873-9880.
34. 1-antitrypsin in mice after direct gene delivery in vivo. Hum. Gene Ther. 3: 641-647.
35. Ohashi, K., et al. (1996). Enhancement of N-nitrosodiethylamine-initiated hepatocarcinogenesis caused by a colchicines-induced cell cycle disturbance in partially hepatectomized rats. Cancer Res. 56: 3474-3479.